Emyria Ltd has released a press release.
Emyria Shares Interim Success in PTSD Treatment Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- Appendix 4E & Annual Report for the Year Ended 30 June 2024
- June 2024 Quarterly Activities Report and Appendix 4C
- Emyria, UWA Secure $499K Grant for MDMA Analogue Program
- Empax Centre Selected As Key Site In Global PTSD Study
- March 2024 Quarterly Activities Report and Appendix 4C
Later from Emyria
- Emyria Gains Ethics Endorsement for Psilocybin Program
- September 2024 Quarterly Activities Report and Appendix 4C
- Emyria & UWA Partner to License Novel Serotonin Therapies
- Response to ASX Price Query
- Emyria Secures $2.525M in Strongly Supported Placement
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria